
Aradhana Sasan
Examiner (ID: 9005, Phone: (571)272-9022 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615 |
| Total Applications | 1310 |
| Issued Applications | 752 |
| Pending Applications | 117 |
| Abandoned Applications | 467 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4927962
[patent_doc_number] => 20080167325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-10
[patent_title] => 'VALACYCLOVIR COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 11/963946
[patent_app_country] => US
[patent_app_date] => 2007-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7324
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20080167325.pdf
[firstpage_image] =>[orig_patent_app_number] => 11963946
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/963946 | VALACYCLOVIR COMPOSITIONS | Dec 23, 2007 | Abandoned |
Array
(
[id] => 4845552
[patent_doc_number] => 20080181960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-31
[patent_title] => 'CAROTENOIDS OF ENHANCED BIOAVAILABILITY'
[patent_app_type] => utility
[patent_app_number] => 11/962311
[patent_app_country] => US
[patent_app_date] => 2007-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8233
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20080181960.pdf
[firstpage_image] =>[orig_patent_app_number] => 11962311
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/962311 | Carotenoids of enhanced bioavailability | Dec 20, 2007 | Issued |
Array
(
[id] => 4813929
[patent_doc_number] => 20080194560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-14
[patent_title] => 'DISINTEGRATION PROMOTERS IN SOLID DOSE WET GRANULATION FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 11/960320
[patent_app_country] => US
[patent_app_date] => 2007-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3422
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20080194560.pdf
[firstpage_image] =>[orig_patent_app_number] => 11960320
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/960320 | DISINTEGRATION PROMOTERS IN SOLID DOSE WET GRANULATION FORMULATIONS | Dec 18, 2007 | Abandoned |
Array
(
[id] => 4682894
[patent_doc_number] => 20080249120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-09
[patent_title] => 'Pharmaceutical compositions'
[patent_app_type] => utility
[patent_app_number] => 12/001807
[patent_app_country] => US
[patent_app_date] => 2007-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4242
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20080249120.pdf
[firstpage_image] =>[orig_patent_app_number] => 12001807
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/001807 | Pharmaceutical compositions | Dec 12, 2007 | Abandoned |
Array
(
[id] => 6046928
[patent_doc_number] => 20110206768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-25
[patent_title] => 'MEDICAL PREPARATION'
[patent_app_type] => utility
[patent_app_number] => 12/517755
[patent_app_country] => US
[patent_app_date] => 2007-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6062
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0206/20110206768.pdf
[firstpage_image] =>[orig_patent_app_number] => 12517755
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/517755 | MEDICAL PREPARATION | Dec 5, 2007 | Abandoned |
Array
(
[id] => 4785054
[patent_doc_number] => 20080138383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-12
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING SEIZURES'
[patent_app_type] => utility
[patent_app_number] => 11/950989
[patent_app_country] => US
[patent_app_date] => 2007-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12972
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20080138383.pdf
[firstpage_image] =>[orig_patent_app_number] => 11950989
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/950989 | COMPOSITIONS AND METHODS FOR TREATING SEIZURES | Dec 4, 2007 | Abandoned |
Array
(
[id] => 4745334
[patent_doc_number] => 20080089936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-17
[patent_title] => 'PROLONGED RELEASE FORMULATION OF ACTIVE PRINCIPLES HAVING A PH-DEPENDENT SOLUBILITY'
[patent_app_type] => utility
[patent_app_number] => 11/949291
[patent_app_country] => US
[patent_app_date] => 2007-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3540
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0089/20080089936.pdf
[firstpage_image] =>[orig_patent_app_number] => 11949291
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/949291 | PROLONGED RELEASE FORMULATION OF ACTIVE PRINCIPLES HAVING A PH-DEPENDENT SOLUBILITY | Dec 2, 2007 | Abandoned |
Array
(
[id] => 4938454
[patent_doc_number] => 20080075773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-27
[patent_title] => 'New Oral Formulation'
[patent_app_type] => utility
[patent_app_number] => 11/947769
[patent_app_country] => US
[patent_app_date] => 2007-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7762
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0075/20080075773.pdf
[firstpage_image] =>[orig_patent_app_number] => 11947769
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/947769 | New Oral Formulation | Nov 28, 2007 | Abandoned |
Array
(
[id] => 4786185
[patent_doc_number] => 20080139514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-12
[patent_title] => 'DIPHOSPHONIC ACID PHARMACEUTICAL COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 11/945507
[patent_app_country] => US
[patent_app_date] => 2007-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6301
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0139/20080139514.pdf
[firstpage_image] =>[orig_patent_app_number] => 11945507
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/945507 | DIPHOSPHONIC ACID PHARMACEUTICAL COMPOSITIONS | Nov 26, 2007 | Abandoned |
Array
(
[id] => 6429961
[patent_doc_number] => 20100143273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'COSMETIC COMPOSITION COMPRISING AT LEAST ONE APROTIC HYDROCARBON-BASED VOLATILE SOLVENT'
[patent_app_type] => utility
[patent_app_number] => 12/516015
[patent_app_country] => US
[patent_app_date] => 2007-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10515
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20100143273.pdf
[firstpage_image] =>[orig_patent_app_number] => 12516015
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/516015 | COSMETIC COMPOSITION COMPRISING AT LEAST ONE APROTIC HYDROCARBON-BASED VOLATILE SOLVENT | Nov 19, 2007 | Abandoned |
Array
(
[id] => 4675731
[patent_doc_number] => 20080213360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'DRY GRANULATION BINDERS, PRODUCTS, AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 11/925375
[patent_app_country] => US
[patent_app_date] => 2007-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6750
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20080213360.pdf
[firstpage_image] =>[orig_patent_app_number] => 11925375
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/925375 | Dry granulation binders, products, and use thereof | Oct 25, 2007 | Issued |
Array
(
[id] => 5585038
[patent_doc_number] => 20090104240
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-23
[patent_title] => 'Dual Drug Formulations For Implantable Medical Devices For Treatment of Vascular Diseases'
[patent_app_type] => utility
[patent_app_number] => 11/875723
[patent_app_country] => US
[patent_app_date] => 2007-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7693
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20090104240.pdf
[firstpage_image] =>[orig_patent_app_number] => 11875723
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/875723 | Dual Drug Formulations For Implantable Medical Devices For Treatment of Vascular Diseases | Oct 18, 2007 | Abandoned |
Array
(
[id] => 4887777
[patent_doc_number] => 20080262109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-23
[patent_title] => 'METHOD FOR PRODUCING LIQUID PREPARATIONS HAVING A SOLID BODY CONTENT'
[patent_app_type] => utility
[patent_app_number] => 11/874155
[patent_app_country] => US
[patent_app_date] => 2007-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17502
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0262/20080262109.pdf
[firstpage_image] =>[orig_patent_app_number] => 11874155
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/874155 | Method for producing liquid preparations having a solid body content | Oct 16, 2007 | Issued |
Array
(
[id] => 4753322
[patent_doc_number] => 20080161398
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-03
[patent_title] => 'STIMULATION OF IN VIVO PRODUCTION OF PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 11/872804
[patent_app_country] => US
[patent_app_date] => 2007-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3967
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20080161398.pdf
[firstpage_image] =>[orig_patent_app_number] => 11872804
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/872804 | STIMULATION OF IN VIVO PRODUCTION OF PROTEINS | Oct 15, 2007 | Abandoned |
Array
(
[id] => 4692548
[patent_doc_number] => 20080085319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-10
[patent_title] => 'LIPIDS CONTAINING OMEGA-3 AND OMEGA-6 FATTY ACIDS'
[patent_app_type] => utility
[patent_app_number] => 11/872258
[patent_app_country] => US
[patent_app_date] => 2007-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13309
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0085/20080085319.pdf
[firstpage_image] =>[orig_patent_app_number] => 11872258
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/872258 | LIPIDS CONTAINING OMEGA-3 AND OMEGA-6 FATTY ACIDS | Oct 14, 2007 | Abandoned |
Array
(
[id] => 4692549
[patent_doc_number] => 20080085320
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-10
[patent_title] => 'LIPIDS CONTAINING OMEGA-3 AND OMEGA-6 FATTY ACIDS'
[patent_app_type] => utility
[patent_app_number] => 11/872440
[patent_app_country] => US
[patent_app_date] => 2007-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13309
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0085/20080085320.pdf
[firstpage_image] =>[orig_patent_app_number] => 11872440
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/872440 | Lipids containing omega-3 and omega-6 fatty acids | Oct 14, 2007 | Issued |
Array
(
[id] => 4746300
[patent_doc_number] => 20080090902
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-17
[patent_title] => 'PHENYLALKYLAMINO CARBAMATE COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 11/868555
[patent_app_country] => US
[patent_app_date] => 2007-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9883
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20080090902.pdf
[firstpage_image] =>[orig_patent_app_number] => 11868555
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/868555 | PHENYLALKYLAMINO CARBAMATE COMPOSITIONS | Oct 7, 2007 | Abandoned |
Array
(
[id] => 4785080
[patent_doc_number] => 20080138409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-12
[patent_title] => 'OLANZAPINE PHARMACEUTICAL COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 11/863795
[patent_app_country] => US
[patent_app_date] => 2007-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3966
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20080138409.pdf
[firstpage_image] =>[orig_patent_app_number] => 11863795
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/863795 | OLANZAPINE PHARMACEUTICAL COMPOSITION | Sep 27, 2007 | Abandoned |
Array
(
[id] => 9607723
[patent_doc_number] => 08784887
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-22
[patent_title] => 'Pharmaceutical preparation of N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide'
[patent_app_type] => utility
[patent_app_number] => 11/904712
[patent_app_country] => US
[patent_app_date] => 2007-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 3716
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11904712
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/904712 | Pharmaceutical preparation of N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide | Sep 26, 2007 | Issued |
Array
(
[id] => 5563589
[patent_doc_number] => 20090136441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-28
[patent_title] => 'Method of fabricating nano-antifouling boat paint'
[patent_app_type] => utility
[patent_app_number] => 11/896734
[patent_app_country] => US
[patent_app_date] => 2007-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 1664
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20090136441.pdf
[firstpage_image] =>[orig_patent_app_number] => 11896734
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/896734 | Method of fabricating nano-antifouling boat paint | Sep 4, 2007 | Abandoned |